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Abstract 
Background 
Radiotherapy (RT) is widely utilised for the management of head and neck malignancies, 
and presents a number of morbidities. One of the most feared late sequelae is 
osteoradionecrosis of the jaws (ORN). Many risk factors for ORN exist including radiation 
delivery, dose and fractionation, tumour location, smoking and alcohol use, general health 
and nutrition status, oral health and oral hygiene. There also exist triggers that increase 
the likelihood of ORN developing, such as dental extractions, surgery or poor fitting 
prostheses as well as any residual foci of infection.  
 
In order to prevent post-radiotherapy dental extractions and therefore reduce the risk of 
developing ORN, it has been advocated that dental extractions are performed prior to 
radiotherapy. However, there is contention that such pre-RT extractions may actually 
increase the risk of developing ORN. Newer RT technologies and techniques deliver a 
lower dose to the jaws and critical structures, and coupled with improved oral hygiene 
methods radiotherapy related dental disease can be limited and the chances of retaining a 
functioning dentition greatly improved.  
 
Head and neck cancer diagnosis and treatment places a heavy stress on patients and 
impacts their quality of life. Independent of a cancer diagnosis, edentulism is associated 
with reduced oral function and health related quality of life.   
 
Aims 
1. To determine if pre-radiotherapy dental extractions are associated with an 
increased risk of developing ORN. 
2. To determine if pre-radiotherapy dental extractions are associated with a reduced 
health related quality of life. 
 
Methods 
Regional and site-specific ethics approval was obtained. Patients over the age of 18 who 
were treated with radiotherapy for oropharyngeal cancer at two tertiary Australian hospitals 
between 2005 and 2011 were invited to participate in the study. All participants were 
presented to a head and neck MDT and underwent pre-radiotherapy dental assessment. 
Demographics and retrospective analysis of the treatment details of the 190 consenting 
participants were recorded. Participants completed questionnaires regarding their oral 
 3 
hygiene, dental extractions and dental experience. A diagnosis of osteoradionecrosis was 
confirmed. Participants also returned two health-related quality of life forms, the OHIP-14 
and FACT-Head and Neck, which were utilised according to their guidelines. The FACT-
Head and Neck results were used to calculate subset scores and the outcome scores 
FACT-G, FACT-TOI and Fact Total. Multivariate logistic regression was performed.  
 
Results 
190 participants were recorded, of whom the majority were male (82.6%) and underwent 
concurrent chemotherapy and radiotherapy (87.9%) with a mean dose of 68 Gray. 67.9% 
underwent pre-radiotherapy dental extractions with a mean of 5.1 teeth. Mandibular teeth 
were favoured 1.7:1. Current smokers were more likely to undergo extractions (p=0.02). 
No teeth were extracted during radiotherapy. 30 participants underwent post-radiotherapy 
extractions, 20 of which after already receiving pre-radiotherapy extractions. The mean 
number of teeth extracted was 0.85 and did not favour either arch.  
 
29 participant (15.3%) developed ORN in the follow up period, favouring the mandible 
(89.6%).  
 
Pre-radiotherapy dental extractions were associated with the development of ORN (OR 
3.19, p<0.05). The number of extractions was associated with an increased risk of ORN 
(OR 1.13 per extraction, p<0.05). Post radiotherapy extractions were associated with a 
similar odds ratio but were not statistically significant. Current and ex-smokers were at an 
increased risk of developing ORN compared with non-smokers, as well as p16 negative 
status. 
 
The range of quality of life outcome scores were broad and nearly encompassed the entire 
possible scores. OHIP-14 scores showed a statistically significant worse QoL for females, 
p16 negative status and stepwise in smoking status from current to ex to non-smokers. 
More than 8 pre-radiotherapy extractions, pre-radiotherapy full clearance and the 
development of ORN also produced statistically significant associations with a worse QoL. 
The only measure associated with an improved QoL was current excellent dental hygiene. 
 
FACT-Head and Neck showed that smoking status was associated with a global reduction 
in QoL across the subset scores emotional well being, social well being, functional well 
being, physical well being and head and neck specific scores. P16 negative cases were 
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associated with reduced QoL in the social well being and head and neck specific domains. 
Female gender was associated with reduced QoL in the emotional well being domain.  
 
Conclusion 
Pre-radiotherapy dental extractions do not appear to reduce the risk of ORN, and may in 
fact increase the risk. Pre-radiotherapy dental extractions do not increase health related 
quality of life, and may in fact worsen it. 
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Introduction 
Dental Management of the irradiated patient 
Head and Neck Cancer (HNC) is often treated with radiotherapy (RT), a method that 
utilises ionizing radiation to exert therapeutic effect by semi-selectively targeting rapidly 
dividing cancer cells. RT produces a number of undesirable effects through the damage of 
normal cells. One of the most feared late complications of RT is Osteoradionecrosis (ORN) 
of the jaws. A number of risk factors exist for ORN, and although spontaneous ORN is 
possible, the condition is often associated with a dentoalveolar trigger event, such as 
dental extractions [1, 2]. RT often results in hyposalivation and can lead to rapidly 
progressive radiation caries, thus leading to the need for multiple extractions [3]. As such, 
patients planned for radiotherapy need to have a comprehensive dental assessment prior 
to treatment commencing, as well as close recall and monitoring. In the first chapter of this 
thesis, a review of the literature will provide contemporary management of the irradiated 
patient prior to, during and following their treatment. 
 
Radiotherapy-associated dental extractions and osteoradionecrosis 
Following radiotherapy, minimisation of dentoalveolar trigger events is key in reducing the 
incidence of ORN. Traditionally, these trigger events were post-radiotherapy dental 
extractions, and clinicians advocated that prophylactic removal of teeth in radiation fields 
would eliminate post-radiotherapy dental complications and thus the need for extractions, 
with the ultimate goal being the reduce the incidence of ORN [4]. Recently, authors have 
begun to investigate pre-radiotherapy trigger events as being related to ORN [4]. As there 
have been no randomised controlled trials investigating radiotherapy-associated dental 
extractions it is currently unclear when the ideal timing for extractions are [5]. Advances in 
both preventative dental management and newer radiation techniques reducing the 
radiotherapy dose to the tooth bearing alveolus and major salivary glands are likely to 
result in increased tooth retention, decreased need for post-radiotherapy extractions and 
decreased incidences of ORN[6]. It is hypothesised that such pre-radiotherapy dental 
extractions are possibly not necessary and may in fact be harmful. The second chapter of 
this thesis will investigate whether dental extractions included as part of the pre-
radiotherapy treatment plan are associated with an increased risk of post-radiotherapy 
ORN. 
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Radiotherapy-associated dental extractions and health-related quality of life 
Head and neck cancer diagnosis places a significant stress on patients and their social 
supports. Additionally, RT as a treatment modality is highly morbid, with impacts on 
speech, mastication, appearance and social interaction [7]. While treatments are designed 
to reduce disease and prolong survival, there has been a recent emphasis on the quality of 
life effects of treatment [8, 9]. A healthy dentition may appear secondary to prolonged 
survival, however it should not be disregarded as an important factor in quality of life, as 
the stomatognathic system is central in aesthetics, communication and diet. As such, any 
plan for dental extractions must weigh the risks and benefits of extraction, looking beyond 
merely the absence of disease and encompassing the psychosocial wellness of the 
individual. It is understood that dental extractions impair quality of life in a general 
population[10], however there are currently no studies investigating how dental extractions 
affect survivors of head and neck cancer. In the third chapter, this thesis will investigate 
the effects of radiotherapy-associated dental extractions and health-related quality of life. 
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Chapter 1 
Dental management of patients irradiated for head and neck cancer 
Australian Dental Journal (2014). 
 
Abstract 
Patients undergoing radiation therapy as either primary, adjuvant, combination therapy or 
palliative management of head and neck malignancies are prone to a range of dental 
complications. Strategies for prevention and management of such complications may be 
controversial. This article aims to highlight the current understanding and management of 
the dental needs for patients before, during and after radiation therapy. 
 
Introduction 
Head and neck cancers (HNC) are often treated with radiation therapy (RT), a technique 
that utilizes ionising radiation and exerts therapeutic effect by semi-selectively damaging 
the genetic material of vulnerable malignant cells, either directly or through the production 
of free radicals, resulting in cell death. 
Adverse effects of RT arise by the same mechanism damaging normal cells, especially 
those that are rapidly dividing, or otherwise less capable of repairing radiation induced 
damage [11]. In the oral cavity these can be cells of the mucous membrane, underlying 
soft tissue, tooth, periosteum, bone, glands and vasculature resulting in specific radiation 
syndromes. Such syndromes include xerostomia and dysgeusia from salivary gland 
damage, mucositis from epithelial damage, pathological alterations in the normal flora 
alterations, radiation caries, reduced mouth opening from changes in collagen structure 
and osteoradionecrosis of the jaw (ORN) from reduced bone healing capacity [12-16].   
 
Management of oral health is especially important for the HNC patient, as oral 
complications are common both during and after radiation. For example, xerostomia may 
affect up to 90% of patients undergoing radiotherapy; mucositis more than 60%; 
candidiasis more than 40%; post-radiotherapy dental decay more than 50%[17] and 
osteoradionecrosis up to 15% [13, 14, 18, 19].  
 
While the majority of oral complications are unavoidable consequences of ionizing 
radiation (deterministic), some are preventable [6]. The incidence of some complications is 
associated with treatment factors, such as in the case of osteoradionecrosis and dental 
extractions [4, 18, 20-22]. As oral complications are common, potentially preventable and 
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have iatrogenic factors, it is essential that those working with HNC patients be aware of 
the prevention and management of radiotherapy-related oral complications.  
 
In this article we aim to highlight the current understanding and management of the dental 
needs for patients who have or will undergo radiation therapy. 
 
Pre-Radiotherapy Dental Assessment 
The benefit of a Multi-Disciplinary Team (MDT) approach to assessing, diagnosing and 
managing head and neck cancer patients is widely acknowledged and as such, every 
patient with head and neck cancer should be managed in this environment[23]. Given the 
oral and dental implications related to treatment, a dental practitioner with experience in 
HNC should be included at the minimum. An expanded dental team would include 
specialists in restoration and rehabilitation as well as health practitioners to educate and 
teach preventative dental care.  
 
At our centre, every patient receives a thorough pre-radiotherapy assessment with an 
experienced general dentist who gives preventative advice and performs necessary 
extractions and fillings. We believe the final oral rehabilitation should be considered at the 
beginning of treatment and as such patients are seen by a specialist prosthodontist. The 
assessment includes consideration of the diagnosis, prognosis, proposed treatment, 
individual patient factors and pre-existing oral health. Immediate management involves 
extractions of unrestorable teeth or those with gross periodontal disease prior to treatment 
irrespective of fields. All healthy teeth as well as deeply impacted teeth without pathology 
are left in situ. Extractions are undertaken with as little trauma as possible and minimal flap 
surgery. 
 
Depending on financial eligibility patients are then referred back to their general dentist 
with a thorough plan or continued to be seen at the clinic. In general, we advise routine 
three-monthly checkups, daily fluoride and bicarbonate rinses and restorations as 
required.  
 
General dental practitioners should be aware of their local MDT and clinics where HNC 
patients are seen and refer patients who present with complications.  
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The cancer diagnosis should include tumour type and staging, location within the oral 
cavity and proximity or involvement of adjacent structures. Human Papilloma Virus (HPV) 
status is an important prognostic factor[24], however a review of the literature does not 
reveal an increased risk of radiotherapy associated complications such as ORN, mucositis, 
candidiasis or xerostomia. 
 
Important treatment factors include the anticipated radiation dose, field size and location. 
Specific areas receiving doses over 60 Gray should be flagged as higher risk for 
complications, especially if the major salivary glands are included. The use of surgery or 
chemotherapy should be known. It is practical to have a rough timetable for treatment and 
follow up appointments. 
 
A full medical and dental history should be taken, as with all patients. Factors likely to 
increase the risk of oral complications should be noted, and the opportunity should be 
taken to discuss risk factor modification, such as smoking and alcohol cessation.  
 
The patient should be assessed for motivation, and whether they are able to manage 
expected dental hygiene regimens. Motivation is of paramount importance but difficult to 
assess. Current dental hygiene habits and prior engagement with dental professionals 
may be of some use. If there are significant concerns with motivation, additional 
appointments with an experience hygienist could help prevent complications. 
 
Finally the oral cavity itself should be examined, and relevant radiographic images 
obtained, such as bitewings and periapicals if indicated. The patient’s general dentition, as 
well as a tooth-by-tooth assessment should be recorded.  If the patient wears dentures 
they should be advised to avoid using them until treatment is completed. 
 
Pre-Radiotherapy Dental Management: Restorations 
The general goals of dental care are no different for HNC patients, that being a functional, 
aesthetic dentition. However, special attention should be given to avoid using patient time 
on extensive treatments.  The goals are made difficult in the HNC population for a number 
of reasons. Firstly, the time interval between decision to treat and the initiation of 
radiotherapy is often short, meaning treatment must be prompt. Secondly, recently 
diagnosed HNC patients have a relatively high prevalence of dental disease[13, 25], with 
one study showing only 11% of patients did not require pre-radiotherapy dental care[26] 
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and up to 50% requiring at least one extraction [13]. Scaling, prophylaxis and fluoride 
application should be performed and where simple restorations are required these should 
be carried out before radiotherapy begins. If time does not permit definitive restoration, 
provisional restoration with a glass ionomer cement is often appropriate. As amalgam may 
cause back-scatter and subsequent local mucositis[27], they are therefore generally 
avoided. The presence of sharp cusps or restorations is an important issue for the HNC 
patient, as these may cause considerable trauma to the vulnerable irradiated soft tissues. 
This is often completely avoidable and can be prevented with simple smoothing or repair. 
Impressions should be taken for study models and the fabrication of soft mouth guards or 
medicament carrying trays at a later date is also prudent. If the patient wears dentures, 
these should be checked to ensure they are well-fitting, and not at risk of causing 
ulceration. 
 
Pre-Radiotherapy Dental Management: Extractions 
The extraction of teeth pre-radiotherapy is a controversial topic. The assumption that all or 
most teeth should be extracted prior to radiotherapy is based on the belief that 
radiotherapy leads to untreatable periodontal disease even in healthy teeth, and that post-
radiotherapy extractions lead to higher rates of complications such as osteoradionecrosis 
of the jaw, in addition to being technically more difficult[4].  
The criteria used by Ben-David et al[6] are a useful guide for extractions: “teeth with non-
restorable caries, or caries that extend to the gum line, teeth with large, compromised 
restorations with significant periodontal attachment loss (pocketing >5mm), and those with 
severe erosion or abrasion are extracted if they are in parts of the jaws expected to 
receive a high dose. Teeth residing in the anterior mandible are not considered for 
extraction unless the primary tumor was in the oral cavity. Decisions about extraction were 
significantly affected by the patient’s competence and interest in performing meticulous 
oral hygiene, and by past history of dental service usage”. Other factors to be taken into 
consideration would include unopposed teeth that would cause trauma to the gums.  
 
There is inconsistent evidence surrounding pre-radiotherapy extractions and their link to 
the development or ORN. Some studies have shown that the lack of pre-radiotherapy 
extractions presents a risk factor for ORN[28], while other studies have found that pre-
radiotherapy extractions are not beneficial in reducing rates of ORN regardless of tooth 
condition [20] and may actually increase the overall risk of ORN [4, 18, 21, 22].  
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If extractions are performed, it is important to allow sufficient healing time prior to the 
commencement of radiotherapy but not to unduly delay it. An accepted interval between 
extractions and radiotherapy is ten days to three weeks[4, 6, 29, 30]. 
 
Dental Management During Radiotherapy: Mucositis 
The oral basal epithelium has a rapid cellular turnover and is therefore at higher risk of 
radiation damage[31]. Cell death and the inability of the mucosa to repair lead to oral 
mucositis (OM), typically presenting as atrophy, swelling, erythema, ulceration and 
pseudomembrane formation, frequently accompanied by colonization with gram-negative 
organisms and candida species. OM can cause considerable pain, as well as functional 
difficulties including eating, drinking and speech [15, 32, 33]. In some cases, nasogastric 
or PEG feeding may be required. 
 
In HNC patients receiving RT, up to 80% of patients may develop mucositis usually 
occurring after 7-10 days of treatment, and potentially lasting for months [32, 34]. The soft 
palate is affected most severely, followed by the hypopharynx, floor of mouth, cheeks, 
tongue and lips[15]. Grading scales such as the World Health Organisation (WHO) oral 
toxicity scale adapted for oral mucositis are useful; Grade 0 is no oral mucositis and Grade 
4 is where the patient has ulcers and alimentation is not possible[35]. 
 
Methods used to prevent and treat mucositis include good dental hygiene such as frequent 
brushing with a soft, regularly replaced toothbrush, regular flossing, four-hourly non-
medicated oral rinses, adequate hydration and the avoidance of oral irritants such as 
alcohol and tobacco. Symptomatic treatment includes tooth mousse and topical barrier 
gels. The Multinational Association of Supportive Care in Cancer (MASCC) and 
International Society of Oral Oncology (ISOO) updated guidelines recommend that 
sucralfate, chlorhexidine and antimicrobial lozenges not be used for the prevention of 
radiotherapy induced oral mucositis, but do state that benzydamine has a role for patient 
receiving moderate dose RT [36].  Other agents that have been investigated include aloe 
vera gels and honey products, which may be beneficial for some patients [37, 38] 
 
In patients with metal fillings, the use of dental-protective stents to prevent scattering may 
reduce the incidence of local mucositis [6]. We recommend that patients receive 
appropriate analgaesia for their pain, and are screened by a dietician to assess their oral 
intake. 
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Dental Management During Radiotherapy: Oropharyngeal Candidiasis 
Oropharyngeal candidiasis (OPC) is caused by both albicans (>80%) and non-albicans 
species, and is a frequent infection after radiation therapy to the head and neck[15, 39]. 
Although candida is a normal oral commensal that occasionally causes infection in healthy 
patients, radiotherapy related hyposalivation alters the oropharyngeal environment and 
significantly increases the risk of colonization and infection. While it may be regarded as 
benign, it can be a significant cause for morbidity and decreased quality of life. 
 
OPC typically affects the tongue, oral cavity and labial commisure, and presents in three 
forms; pseudomembranous, erythematous/atrophic and cheilitis [39]. The usual 
appearance is that of removable white lesions overlying an erythematous and atrophic 
patch. Symptoms may be absent or include burning pain, difficulty swallowing, dysgeusia, 
and halitosis.  
 
OPC is treated when symptomatic and focuses on local therapy unless the presentation is 
severe, disseminated candidiasis is suspected, the patient is high risk (i.e. 
immunosuppressed) or fails to respond to local methods. Prevention is through regular 
dental hygiene, saliva substitutes and smoking and alcohol cessation. First line treatment 
includes topical miconazole, fluconazole or nystatin, available in several forms such as 
creams, suspensions or lozenges. When systemic therapy is indicated, the first line drug is 
oral fluconazole.  
 
Dental Management During Radiotherapy: Xerostomia 
Radiation damage to the salivary glands, especially the parotids, results in gland 
dysfunction through cell death and fibrosis. The result is hyposalivation and increased 
salivary viscosity experienced as xerostomia. Xerostomia causes functional issues within 
the oral cavity, affecting speech and taste, as well as causing chewing and swallowing 
difficulties. Furthermore, hyposalivation increases the risk of developing oral infections 
such as candidiasis, gingivitis and acute suppurative sialadenitis, as well as increasing the 
risk of developing caries[12].  
  
The incidence of xerostomia is related to the tumour location and technique used to deliver 
radiotherapy, as well as the dose delivered. Even small doses can result in a large 
proportion of glandular destruction. Newer radiotherapy techniques such as intensity-
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modulated radiotherapy (IMRT) avoid larger radiation doses to the parotids, and retain 
greater function[40]. 
 
There are a number of methods that propose to reduce xerostomia, such as amifostine, 
intra-glandular botulinum therapy and alpha-tocopherol, however these may not produce 
the desired effect. Currently systemic treatments for the prevention of xerostomia are only 
used in a research setting[12]. 
 
Management of xerostomia begins with the same methods as all other radiotherapy 
syndromes- good oral hygiene. This reduces the severity of xerostomia as well as 
preventing secondary complications such as caries. Salivary substitutes should be used 
for symptom relief, as well as regular non-medicated oral rinses. Sialogogues such as 
chewing gum and the cholinergic agonist pilocarpine can also be used for relief of 
symptoms and may offer some dental protection, however adverse effects of pilocarpine 
such as sweating, diarrhoea and bronchospasm may limit its use in some people[12, 34]. 
 
Dental Management During Radiotherapy: Emergencies 
A thorough pre-treatment assessment and management of incipient dental conditions 
should ideally prevent dental emergencies during radiotherapy. 
Cessation of radiotherapy treatment is to be avoided as delays reduce treatment 
effectiveness and therefore survival[41]. 
 
Before treating, contact should be made with the treating radiation oncologist and the 
nature of the condition discussed. Acute onset of toothache may be successfully managed 
with standard restorative or endodontic techniques, although increased difficulty should be 
anticipated due to radiation mucositis, general discomfort and limited mouth opening. 
 
Dental extractions are a troublesome issue, and due to technical difficulty and increased 
complication there should be a low threshold for tertiary referral, especially if the teeth fall 
within the radiation field. If indicated, they should be performed with minimal trauma by an 
appropriate specialist. 
 
Post-Radiotherapy Management: Hygiene and Radiation Caries 
Following radiation, chemical and microbial changes in the oral cavity result in a cariogenic 
environment[34]. Over half of all patients will demonstrate dental deterioration over time 
 23 
with an incidence risk of 6% per month[17]. Radiation caries occurs even in teeth not 
exposed to radiation, and if not managed can progress to full dental loss over a period of 
as little as three years[42].  
 
Incidence is related to radiotherapy dose, with an odds increase of 2-3 at 30-60 Gy, and 
10 at over 60Gy. The proposed mechanism is that the salivary glands withstand doses up 
to 30Gy and sustain maximal damage between 30-60Gy. The additional risk is due to 
direct radiation effects on the tooth structure, which weakens dentin-enamel bonds and 
results in shear fracturing[17].  
 
Radiation caries occur at different locations than in common dental decay. The sites most 
affected post-radiotherapy are the labial surfaces of the cervical, cuspal and incisor areas. 
These areas receive compression, torsion and shearing forces and are the regions most 
resistant to caries in non-irradiated patients[17, 34].  
Prevention is key. Use of fluoride in medicament carrier trays dramatically reduces the risk 
of dental deterioration, and prescription fluoride should be used at least once daily. In one 
study, each additional daily use of fluoride per week resulted in a 14% reduction in 
moderate or severe dental deterioration[17].  
Additional preventative techniques include dental hygiene measures such as regular 
rinses, brushing, flossing and the management of xerostomia. Rinses should be either 
non-acidic fluoride preparations or bicarbonate preparations, and brushing and flossing 
should be gentle and thorough.  
 
Post-Radiotherapy Management: Restorative Considerations 
Restorative management of radiation caries can be challenging and may be compounded 
by limited access due to trismus or scarring and poor moisture control as a result of 
marginal gingivitis. The restorative dentist must consider these challenges, along with an 
altered dental substrate and a hostile oral environment when selecting restorative 
materials. Ideal properties would include resistance to recurrent caries, adhesion to tooth 
structure, durability, acceptable aesthetics and ease of handling. None of the currently 
available materials meet this standard and there is only limited evidence in the literature to 
guide material choice. 
 
Radiation induced changes in enamel and dentine may compromise bonding of adhesive 
materials[43] though the extent and mechanism of such changes are controversial. Some 
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studies have indicated altered prismatic structure within enamel and reduced physical 
properties [44, 45] while others have failed to demonstrate significant enamel changes. 
Water molecules in dentine undergo radiolysis releasing free radicals which denature 
collagen and reduce its mechanical properties[46]. Free radicals can interfere with 
polymerization of resins while irradiation also activates enzymes including matrix 
metalloproteinases (MMPs) within dentine, which have been shown to hydrolyse dentine 
bonding agents[47]. Consequently, loss of retention or development of recurrent caries 
around composite restorations is often observed[48].   
 
Glass ionomers cements (GICs) lack strength however they do enjoy simpler bonding 
procedures and chemical adhesion as well as fluoride release and reuptake, which may 
reduce recurrent caries, even if the material is subsequently lost[49]. De Moor et al[48] 
demonstrated significantly less recurrent caries around Class V GICs compared to resin 
composites in irradiated patients. This difference was particularly marked when fluoride 
use was low. Resin Modified Glass Ionomers (RMGICs) have improved structural and 
marginal integrity, similar recurrent caries rates and greater resistance to acid erosion so 
may be good alternatives to conventional GICs. What evidence is available suggests that 
where caries risk is high or patient compliance is poor, GICs (conventional or resin 
modified) are the materials of choice.  
 
Extensive caries increases the risk of pulpal involvement. Irradiation may alter pulp 
vascularity and therefore its capacity for repair[50]. Within radiation fields, where caries 
involves the pulp, endodontic treatment is generally preferred to extraction. Even teeth 
deemed un-restorable may be root filled and sealed to control symptoms and infection 
while minimizing the risk of ORN. Trismus and poor access can however complicate root 
canal therapy. Rubber dam placement may be challenging and a lack of inter-occlusal 
space may prevent ideal canal access. Cutting access cavities through the labial or incisal 
aspects or decoronating grossly carious teeth may be an acceptable compromise. 
Success rates of endodontics in irradiated patients have received limited attention in the 
literature but seem to be acceptable[51]. 
 
Crown and bridgework is generally avoided in xerostomic patients. Unless compliance with 
preventive advice is optimal, restoration margins will be vulnerable to recurrent caries. In 
compliant patients with a stable dentition, simple indirect restorations may be considered. 
Margins should be kept supra-gingival and hygienic design is essential.  Craddock[52] 
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demonstrated that fixed prosthodontic rehabilitation can prove successful over several 
years.    
 
Generally removable prostheses should be avoided in irradiated partially dentate patients 
unless they are essential for aesthetics or function. It is accepted that partial dentures 
compromise plaque control[53] and that a shortened dental arch is often adequate for 
function and aesthetics[54]. Where they are unavoidable their design should be hygienic 
and patients must be counseled regarding the risks and strongly encouraged to maintain 
impeccable oral and denture hygiene. Care should also be exercised when providing 
dentures for patients who have undergone pre-radiotherapy extractions. Particularly where 
dentures are tissue borne, there is a risk of trauma and ORN careful clinical technique 
should be supplemented with patient education and regular recall. Conventionally, denture 
provision has delayed for 12 months or more after completion of radiation to allow healing 
and ridge remodelling. This has been questioned in recent years with one study showing 
similar complication rates whether dentures were inserted within 6 months or delayed by 
up to a year[55]. 
 
Post-Radiotherapy Management: Extractions and Osteoradionecrosis 
Osteoradionecrosis is a serious and typically late complication following radiation therapy 
to the head and neck whereby irradiated bone is exposed and undergoes necrosis. The 
exact pathophysiology is unclear and a number of proposed mechanisms exist, from 
Marx’s ‘three Hs’ theory through to the current fibroatrophic theory[56]. 
 
A great number of staging systems exist for ORN (Table 1)[57]. One of the first methods 
was Marx’s system where stage was based on response to the Wilford Hall hyperbaric 
oxygen protocol, with potential to directly enter a higher stage if the initial presentation was 
severe[58]. More contemporary systems such as Kagan and Schwartz’s three stages 
classify ORN based on clinical presentation, and then treatment is decided according to 
the stage[1]. A simple system is presented by Notani et al based on clinical 
presentation[59]. Staging systems have focused on the mandible, as the maxilla is unlikely 
to develop ORN. 
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Table 1.1 Selected staging systems for ORN 
 
Preventative measures are vital to avoid the need for dental intervention such as 
extractions and may have led to a significant decline in rates of ORN over the last few 
decades[60]. However, even with adequate care, the extraction of diseased teeth may 
become inevitable. A minimal trauma technique is especially indicated in the irradiated 
patient and therefore experienced clinicians should perform the procedure. In addition, 
investigators have proposed that the number of teeth removed in a single session should 
be limited, and specific local anaesthetics should be avoided, however data for these 
recommendations appear to be lacking and should be further investigated before they 
have an impact on clinical practice [3, 61, 62]. 
 
In order to further reduce the rates of ORN, clinicians have used prophylactic antibiotics, 
platelet-rich plasma (PRP) and steroids in order to reduce osteoradionecrosis, however 
none of these methods have resulted in a consistent and significant reduction in the rates 
of ORN and are not without their own risks. The use of prophylactic and therapeutic HBO 
for ORN is controversial. 
 
In general we advise that General Dental Practitioners consider endodontic treatment first, 
to avoid extractions. Should this fail or if extractions become necessary, General Dentists 
can safely extract teeth out of field or in fields less than 50 Gray with primary closure of the 
socket. Teeth in fields greater than 50 Gray should be referred to the treating Oral and 
Maxillofacial Surgery department. 
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Post-Radiotherapy Management: ORN and Hyperbaric Oxygen 
The theoretical benefit of HBO links in with one of the proposed mechanisms of 
osteoradionecrosis, where ORN is the result of ‘hypoxia, hypocellularity and 
hypovascularity’. HBO promotes angiogenesis, and therefore should reduce ORN [16]. 
The standard Marx 30/10 HBO protocol consists of 30 treatments at 2.4 atmospheres for 
90 minutes prior to extraction, followed by 10 treatments of 90 minutes post-extraction.  
 
A number of criticisms of HBO for the prevention and treatment of ORN exist. A recent 
systematic review found no benefit when prophylactic HBO is used in associated with 
extractions [63], and another pooled the overall complication rate for patients undergoing 
HBO, revealing a complication incidence of about 7.8%, including minor symptoms 
through to seizures, stroke and death[4, 64]. The only randomised, controlled trial was 
conducted by Annane et al in 2004 and was stopped due to potentially worse outcomes in 
the HBO group[65]. Additional criticism is that studies of prophylactic HBO have been few 
in number, contain a small sample size and are generally dissimilar [4, 66].  
 
These criticisms must be contrasted with the positive findings from a number of studies, 
including pooled data. A recent systematic review showed weak evidence that HBO 
reduced the rate of post-radiotherapy extraction related ORN from 7% to 4%[61], a 
Cochrane review published in 2012 showed some benefit for therapeutic HBO in regards 
to mucosal cover and prevention of wound dehiscence but concluded that more and better 
quality data was needed[67]. It is promising therefore, that larger trials are underway[68]. 
 
Post-Radiotherapy Management: ORN, Antibiotics and PRP 
The use of antibiotics has been advocated for the prevention of ORN, which, although 
unproven, has been theorized to be an infectious process, or at least process in which 
bacterial play a role [4]. A questionnaire of practitioners revealed there was no consensus 
on the type or duration of antibiotics used, although a general trend was to use antibiotics 
that cover both aerobic and anaerobic bacteria[69]. There is weak evidence to suggest 
that the use of antibiotics in general confers a 1% absolute risk reduction in ORN 
compared to no antibiotics. Despite only weak evidence, prophylactic antibiotic use is still 
common following extractions[61]. The authors do not encourage use of antibiotics where 
there is no infection. 
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Autologous PRP has been promoted for various applications, including bone grafts and 
various head and neck procedures. The theoretical mechanism of prophylaxis is that a 
number of growth factors present in platelets, including PDGF, TGFβ and VEGF, result in 
improved healing and better outcomes. A recent randomized controlled trial showed no 
relationship between PRP use and development of ORN or improved pain scores[18]. It is 
reasonable to conclude that the use of PRP should be questioned in this setting. 
 
Post-Radiotherapy Management: ORN, Pentoxyfylline and Tocopherol 
Pentoxyfylline, a phosphodiesterase inhibitor used in peripheral vascular disease, and 
tocopherol (vitamin E) are used with or without the bisphosphonate clodronate as a novel 
combination therapy for the management of ORN.  Current studies show impressive 
outcomes with these drugs, such as a study where 54 patients with refractory ORN all 
experienced full recovery in a median of nine months[70-72]. Similar studies have not all 
shown the same outcomes, and as such more research is needed in this field[73]. 
 
Post-Radiotherapy Management: Treatment of Osteoradionecrosis 
For the patient who develops ORN, prompt referral should be made to a tertiary 
maxillofacial unit for further management. Treatment of ORN ranges from conservative 
methods such as saline rinses through to debridement, sequestrectomy, resection and 
free flaps, with or without the use of adjuncts such as HBO or pentoxyphylline, tocopherol 
and clodronate [70-72, 74, 75]. 
 
Follow-up and Discharge 
Follow up should be performed by a head and neck cancer multidisciplinary team at units 
approved for the diagnosis and management of head and neck cancers. Discharge back to 
the community dentist is appropriate if the patient has successfully completed all 
treatments and has no active complications. The community dentist accepting the patient 
should have an understanding of the dental needs of irradiated patients and a knowledge 
of when to re-refer. 
 
From a dental perspective, regular dental follow up should be every three months. This 
ensures education is reinforced and any dental issues are addressed early. The dental 
consultation should review the treatment course and cover any history of complications. 
The patient’s dental hygiene and regular dental routine should be assessed, and any 
opportunities for education should be taken advantage of. The patient should then be 
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examined and any necessary management enacted. Finally, it is of great value to the rest 
of the team to receive letters detailing the patient’s dental visits and opinions of the dental 
practitioner. 
 
Conclusions 
The management of the patient irradiated for head and neck cancers is an excellent 
opportunity for preventative care. There are a number of proposed adjunct therapies for 
the prevention and treatment of complications, however few of these are supported by 
strong evidence. Further research is necessary in multiple areas, in particular pre-
radiotherapy extractions and the use of hyperbaric oxygen. 
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Chapter 2: 
 
Radiotherapy-associated dental extractions and osteoradionecrosis 
 
Head and Neck (2016) 
 
Introduction  
Radiotherapy (RT) is widely utilised for the management of head and neck malignancy and 
is associated with significant morbidity, manifest during treatment and often persisting 
permanently. One of the most feared late sequelae is osteoradionecrosis of the jaws 
(ORN), a condition of impaired wound healing characterised by non-vital bone in radiation 
fields not related to tumour recurrence[1]. Many risk factors for ORN exist including 
radiation delivery, dose and fractionation, tumour location, smoking and alcohol use, 
general health and nutrition status, oral health and oral hygiene. There also exist triggers 
that increase the likelihood of ORN developing, such as dental extractions, dental 
implants, surgery or poor fitting prostheses [2] as well as any residual foci of infection[76]. 
 
In order to minimise the risk of ORN and other radiation-related negative effects on the 
oral cavity, it is recommended that all patients are seen by a dental clinician prior to the 
commencement of treatment. At this visit, the oral status is assessed and appropriate 
dental treatments are completed. The dental needs of patients diagnosed with HNC are 
often quite high, and patients frequently present with periodontal disease and caries [13]. 
 
At the pre-RT dental review, extractions are often performed. The timing of such dental 
extractions is important to note, as controversy exists regarding best practice for extraction 
[4]. Some authors in the past have advocated various regimens in order to prevent dental 
extraction in the post-radiation period. The rationale behind these regimens is usually as 
follows: that chances of needing dental extraction in the post-radiation period have 
traditionally been higher due to altered oral function eg hyposalivation, radiation caries 
occurs, the extractions are technically more challenging due to radiation complications 
such as trismus and post-RT extractions increase the risk of developing ORN [3]. It should 
be noted that a recent Cochrane review has not found any randomised controlled trials 
studying the extraction of teeth prior to RT[77]. 
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Recently, some authors have claimed that such pre-RT extractions may actually increase 
the risk of developing ORN [4]. Newer RT technologies and techniques, such as dynamic 
and static intensity modulated RT, deliver a lower dose to the jaws and critical structures 
such as the parotid glands without compromise to the tumour dose. Coupled with 
improved oral hygiene methods both ORN and the development of post-RT dental 
disease, is likely to result in an improved probability of retaining teeth [6, 78].  
 
The aim of this study was to examine the impact of dental extractions on the development 
of ORN. 
 
Materials and Methods 
Participant selection 
Patients over the age of 18 with oropharyngeal cancer treated with curative intent definitive 
and/or postoperative RT at two tertiary hospitals in an Australian state capital from 2005-
2011 were invited to participate in the study. Patients underwent treatment planning 
through a multidisciplinary head and neck clinic and all received dental assessment, 
primary dental treatment and oral hygiene instruction before being discharged back to 
community dental clinics. Oropharyngeal cancer was chosen specifically as the standard 
treatment is chemoradiation, providing radiation delivery to the jaws. The dates chosen 
allowed sufficient post-treatment time to capture late complications, specifically ORN.  
Institutional ethics approval was obtained and participants provided written informed 
consent. 190 participants completed the study, and 47 declined to participate. Data was 
collected between July and December 2014. 
 
Data collection 
Consenting participants had their demographic and treatment data retrieved from hospital 
databases. Age, gender and smoking status were recorded. Diagnostic data included 
tumour location, tissue diagnosis, p16 status and TNM classification. Treatment data 
included radiation dose and site as well as the use and synchronicity of chemotherapy.  
Participants were given questionnaires requesting further information regarding their 
dental health and treatment in the preceding months before, during and following RT. 
Specifically, the location, timing and number of dental extractions were recorded. 
Subjective dental hygiene was recorded for pre- and post-treatment and participants were 
asked to disclose dental habits, denture use and service utilisation. The questionnaire 
gathered information regarding exposed bone after radiation treatment including duration, 
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quadrant location and treatment with either surgical intervention and/or hyperbaric oxygen. 
Location site was confirmed with medical records and radiographs. 
 
All data was de-identified, tabulated and stored in a secure database.  
A diagnosis of ORN was recorded where an area of exposed bone was present in 
radiation fields for at least 3 months, and/or required treatment with surgical intervention or 
hyperbaric oxygen therapy without evidence of tumour recurrence.  
Data underwent statistical analysis provided by an independent external statistician using 
Stata statistical software v12.0 (Statacorp, College Station, TX, USA).  
 
Results 
190 participants met the criteria and were included in the study, of which 132 (69.5%) were 
from hospital 1, and 58 (30.5%) were from hospital 2.  157 (82.6) were males and 33 
(17.3%) were females. The mean age was 64.9 (34.1-89.0, SD 8.3) with mean female age 
61.2 and mean male age 65.7. (Table 2.1). 
 
Tumour Site Cases T Stage Cases Prog 
Stage 
Cases 
Tonsil 102 TX 2 Stage I 5 
Base of 
Tongue 
68 T0 3 Stage II 8 
Soft Palate 3 T1 44 Stage III 31 
Oropharynx 
Other or 
Unspecified 
17 T2 66 Stage 
IVA 
134 
P16 status Cases T3 43 Stage 
IVB 
7 
Positive 102 T4a 27 Not 
recorded 
5 
Negative 15 T4b 1   
Unknown 73 T Not 
recorded 
4   
Smoking 
status 
Count N Stage    
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Current 
smoker 
24 N0 22   
Ex-smoker 78 N1 32   
Non-smoker 40 N2a 19   
Unknown 48 N2b 74   
Morphology Count N2c 24   
Squamous 
cell 
carcinoma 
181 N3 6   
Other 9 N Not 
recorded 
4   
Table 2.1 Participant demographics 
 
Treatment Modality 
All participants underwent curative intent RT as required by the study protocol. 167 
(87.9%) underwent concurrent chemotherapy and RT. 21 (11.1%) underwent RT alone, 
and 2 (1.1%) underwent sequential chemotherapy and RT. The mean RT dose 
administered was 68 Gray (30-77, SD 5.9). 
 
Pre-Radiotherapy Dental Extractions 
4 participants (2.1%) were edentulous prior to treatment. 129 (67.9%) of participants 
underwent dental extractions as part of their pre-RT treatment. 13 of this group underwent 
full clearances. It is important to note that of 129 cases who had pre-RT extractions, 20 
(15.5%) went on to have post-RT extractions, leaving 109 having only pre-RT extractions. 
The mean number of teeth extracted for all cases was 5.1 (Range 0-24, SD 5.4). Teeth 
were extracted prior to RT at a total of 364 quadrant-extractions. More extractions were 
performed in the mandible at a ratio of 1.7:1. Quadrants 1 to 4 had 77, 72, 102 and 113 
quadrant-extractions respectively. Current smokers were more likely to have pre-RT 
extractions (p=0.02). (Table 2). 
 
Pre- and Post-
Radiotherapy Dental 
Extractions 
Count % of Total 
Pre-RT (total) 129 67.9% 
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Pre-RT (only) 109 57.4% 
Pre-RT Full Clearance 13 6.8% 
During RT 0 0% 
Post-RT (total) 30 15.8% 
Post-RT (only) 10 5.3% 
Pre- and Post-RT 20 10.5% 
Pre- and/or Post-RT 139 73.2% 
No extractions (Dentate) 47 24.7% 
Edentulous prior to 
treatment 
4 2.1% 
Table 2.2 Dental extractions 
 
Extractions during radiotherapy 
No participants had dental extractions during RT. 
 
Post-Radiotherapy Dental Extractions 
30 participants underwent post-RT extractions, with 10 cases having them alone. The 
mean number of teeth extracted after RT for all cases was 0.85 (Range 0-20, SD 3.0). 
Teeth extracted post-RT were balanced across the mouth, with extractions from quadrant 
1 to quadrant 4 as 16, 15, 15 and 16 respectively. 
 
Osteoradionecrosis 
29 participants (15.3%) had developed ORN at the time of the study. ORN developed in 
the mandible for 26 participants, and maxilla for 3 participants.   
 
25 of the 29 cases of ORN (86.2%) occurred in participants who underwent pre-RT 
extractions, and 22 of the 29 cases of ORN (75.9%) were in sites of pre-RT extraction. Of 
the 25, 2 cases of ORN developed in participants who had full clearances, and 5 
developed in participants who had both pre- and post-RT extractions. 
 
4 cases of ORN (13.8%) developed in the site of post-RT extraction, and 3 (10.3%) were 
in the same quadrant that had undergone both pre- and post-RT extractions. 2 dentate 
participants developed ORN without undergoing pre- or post-RT extractions. No 
participants who were edentulous at the beginning of treatment developed ORN. 
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Oral Hygiene Status 
Oral hygiene status was self reported, with an overall status, brushing times per day and 
dental visits per year recorded. Participants gave scores for their hygiene both pre- and 
post-RT, reported as poor, fair, good or excellent. Post-treatment the results polarised and 
the excellent and poor groups made net gains (Table 3). 
 
Oral Hygiene Poor Fair Good Excellent 
Pre-RT 2.6% 19.6% 57.7% 20.1% 
Post-RT 5.8% 11.6% 42.9% 39.7% 
Net change +3.2% -7.9% -14.8% +19.6% 
Table 2.3 Oral Hygiene 
 
Dental Extractions 
Linear regression testing different subgroups of extractions as variables and development 
of ORN as the outcome yielded a number of significant results. Pre-RT dental extractions 
regardless of post-RT extractions, in isolation, combined with post-RT extractions in toto or 
using an and/or approach resulted in an increased odds of developing ORN at the 95% 
level, specifically 3.19, 5.19, 7.50 and 5.42 respectively. 
 
No extractions were performed during RT. 
 
Post-RT extractions were analysed using the same method, however in the categories 
described yielded significant results only when grouped with pre-RT extractions. It is 
important to note however, that the sign was positive despite lack of significance. 
 
The numbers of extractions were tested either as a continuous quantitative variable per 
extraction and as a series of quantitative groups, specifically zero, one to zero and greater 
than eight, using zero as the control. Participants had 0 to 24 teeth extracted pre-RT. The 
odds were 1.13 per extraction and were significant at the 95% level. In the discrete groups 
there was significance for extractions greater than eight, with odds of 5.28, compared no 
zero extractions. For post RT extractions, with a range of 0-20, the same significance was 
not demonstrated in the post-RT group for either number as quantitative, or discrete as 
zero, one or greater than one, despite again having a positive odds. (Table 4). 
 
 36 
Extraction  OR p 95% CI 
Lower 
95% CI 
Upper 
Pre, regardless of post  3.19 0.040 1.05 9.62 
Post, regardless of pre  1.87 0.21 0.71 4.93 
Post, not pre 5.62 0.11 0.69 45.90 
Pre, not post 5.19 0.032 1.15 23.42 
Pre and post 7.50 0.023 1.32 42.77 
Pre and/or post, ‘any 
extraction’ 
5.42 0.025 1.24 23.76 
Pre, number (quant, cont), per 
exo 
1.13 0.001 1.05 1.21 
Pre, 1-7 (qual) 1.66 0.44 0.46 5.98 
Pre, >8 (qual) 5.28 0.005 1.67 16.73 
Post, number (quant, cont), 
per exo 
1.06 0.27 0.95 1.18 
Post, >1 (qual) 1.85 0.21 0.71 4.84 
Table 2.4 Dental extractions and osteoradionecrosis 
 
Pearson chi-squared test was used to determine if the development of ORN was related to 
pre-RT extractions in the same quadrant, reporting chi2(1) 11.02 (Pr=0.001), indicating a 
significant association. 
 
Additional variables were tested to assess their effect on development of ORN, with 
significant increased odds returning for current smoking status between current smokers 
(C), and ex-smokers (E) and non-smokers (N), (OR 3.6, p=0.028) and p16 status negative 
(OR 9.04, p<0.001). Site and morphology did not return any significant results. (Table 5). 
 
Variable OR p 95% CI 
Lower 
95% CI 
Upper 
Smoking, C v 
E 
3.60 0.028 1.15 11.32 
Smoking, C v 
N 
2.88 0.11 0.80 10.43 
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P16, -ve 9.04 <0.001 2.66 30.73 
Gender, male 1.98 0.29 0.056 6.99 
Age, per year 1.012 0.59 0.097 1.06 
Hospital 1.03 0.91 0.44 2.42 
Table 2.5 Demographics and osteoradionecrosis 
 
Multiple logistic regression was then performed using age, p16 and smoking status, and 
pre and post-RT extractions. Significant results were returned for p16 status (coeff 0.093, 
p=0.049) and pre-RT extractions (coeff 0.13, p=0.025). Post-RT extractions effect size was 
comparable but not significant (coeff 0.098, p=0.18). 
 
Participants who declined to be involved 
Limited data was available for those who declined to be involved in the study. From what 
data was available, the demographics of this group were similar to that of the study 
population. The mean age was 61 compared to 64.9 of the study group, slightly fewer 
males (76% compared with 82%), similar site of disease (majority tonsil followed by base 
of tongue), radiotherapy dose 65 compared with 68Gy. Disease severity showed a similar 
distribution, however there was a trend towards higher T1 in the declined group (36% 
compared with 23%) and lower T4a in the declined group (9% compared with 14%). Nodal 
disease was matched for both groups.  
 
Discussion 
In this study, pre-RT dental extractions were shown to significantly increase the odds of 
developing ORN, regardless of whether the extractions were exclusive or inclusive of post-
RT extractions. The odds of developing ORN were increased in comparable amounts 
when post-RT extractions were tested against no extractions, however this was found to 
be statistically insignificant.  
 
However, there were a far greater number of participants receiving pre-RT extractions 
(129 cases) compared with those receiving post-RT extractions (30 cases). As a tooth can 
only be extracted once, it is not unreasonable to suggest that you can reduce pre-RT 
extractions by delaying these for 6 weeks or so and thus produce a greater number of 
post-RT extractions. The same logic would follow that this would present the same or 
increased risk of ORN, however now attributing it to the post-RT extractions. This is, 
however, the exact reasoning but with the reverse effect that has resulted in such a large 
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number of pre-RT extractions being undertaken, and has been shown in this study to not 
reduce the risk of ORN. The alternate hypothesis is that it is not either pre-RT extractions 
or post-RT extractions that is the culprit, but extractions in general are, regardless of 
timing. This could be extended to oral health, as the root cause of extractions through 
caries or periodontal disease, is the cause of the increased risk of developing ORN, as 
some researchers have found. It should be highlighted that patients with poor oral health 
are more likely to undergo dental extractions, thus placing them at higher risk of 
developing ORN [79, 80]. 
 
If pre-RT extractions are taken on an intention to treat, ie regardless of post-RT extraction 
status, the odds ratio of developing ORN are 3.19 (p=0.040). Decanting this by removing 
post-RT extractions increases the odds ratio to 5.19 (0.032). It is interesting that these 
odds are similar to post-RT extractions (excluding pre-RT extractions) with odds of 5.62 
(p=0.11). What is more interesting is that these pre-RT extractions do not appear to 
protect against post-RT extractions, as two thirds of the post-RT extraction group had pre-
RT extractions as well. The other third (n=10), represent only 16.4% of the group who had 
no pre-RT extractions. If ‘any extraction’ is used as the variable, the odds ratio remains 
similar to that of either pre- or post-RT extractions, however is now significant (OR 5.42, 
p=0.025).  
 
It would make sense that if ‘any extraction’ increases the risk of developing ORN then an 
increased number of extractions would increase the odds of developing ORN, and this is 
exactly what was found. When pre-RT dental extractions increase, the odds of developing 
ORN increase by 1.13 per tooth extracted (p=0.001). For post-RT extractions the odds 
increased at a smaller, insignificant rate (1.06, p=0.27). For those that had both pre- and 
post-RT extractions, the odds of developing ORN were incredibly high (7.50, p=0.023), 
which is related to increased extraction number, extraction incidences and, likely, an 
underlying oral health issue. 
 
The hypothesis that any extraction increases the risk of ORN, raises a number of 
questions. Firstly, should sound teeth in radiation fields be extracted prior to RT? 
Secondly, can compromised or ‘borderline’ teeth be left or restored prior to RT and have a 
reasonable prognosis? And thirdly, if teeth are hopeless and must be extracted, when 
should this be performed? While this study did not look at the extraction indications, the 
findings can shed light on these questions. 
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Extraction of sound teeth, ie those that would not be extracted in participants not planned 
for RT should not be performed in those who are planned for RT, as these extractions 
increase the risk of developing ORN, and may reduce the post-treatment quality of life.  
 
Extraction of compromised teeth, ie those that would generally not be extracted in 
participants not planned for RT but would require some degree of restoration, requires 
good clinical judgement. The oral cavity will undergoing significant stress in the post-
irradiation period, however the dentition can be maintained[6]. Guidelines for management 
of the irradiated patient have been published by the authors in the past [81]. It should be 
noted as an alternative to extraction, endodontic treatment is successful in the irradiated 
patient[51, 82, 83] and to date is not associated with ORN. 
 
Extraction of hopeless teeth, ie those that would be extracted regardless of RT planning, 
does not warrant an argument against performing the extractions, but rather the timing of 
such extractions. If performed prior to RT, the rapid turnover of bone in the healing socket 
is exposed to RT – the oncologic management cannot be delayed until the socket has 
achieved full bony resolution. If performed afterwards, the extraction is now performed in 
conditions of compromised healing. Both instances are less than ideal, and there is no 
current evidence to determine when is the best time for extraction. 
 
Further Research 
High quality evidence requires high quality data, although it is not possible to blind 
participants or researchers against extraction and not ethical to assign someone to 
randomly having their teeth extracted. A prospective study with meticulous data collection 
would be the only feasible solution. If the teeth were required to be extracted, a useful 
study would be on the timing of such extractions- should they occur in the pre-RT period 
when time prior to treatment is limited, or can they be delayed until the immediate post-RT 
period? 
 
Limitations 
It is prudent to address the limitations of a study before discussing the merits of the results 
so as to ensure the outcomes are viewed in the correct light, and, more importantly, that 
future studies may be planned accordingly to account for such limitations and produce 
higher quality data. 
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In this study, there are number of limitations. There is no true control, nor is there a pre-
treatment quality of life baseline, and there is evidence to suggest that longer term quality 
of life relates to baseline[84, 85]. Due to the nature of the study design, there are 
opportunities for bias to occur with participants selecting into and out of the study due to 
personal reasons, for example, developing ORN and desiring to express their concerns. 
Additionally there is survivorship bias, as all participants have been able to complete the 
requirements of the study, which selects for p16 positive malignancies and the inherent 
prognostic factors [9, 86]. 
 
It would have been ideal for the participants to have had each tooth individually assessed 
by the same clinician in the pre-RT period, and record details such as extraction indication, 
extraction procedure use of adjuvants and time to RT, as well as provide comparison with 
the same patients at follow up, but this was not possible due to the study design.  
 
Conclusion 
Pre-RT dental extractions do not appear to protect against ORN. With improved prevention 
methods and dose limiting technology the chances of long-term tooth retention are greatly 
improved. 
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Chapter 3: 
 
Pre-radiotherapy dental extractions and health-related quality of life 
 
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology (2016) Under Submission 
 
Introduction  
Radiotherapy (RT) is widely utilised for the management of head and neck cancer (HNC) 
and is associated with significant morbidity, manifest during treatment and often persisting 
permanently. One of the most feared late sequelae is osteoradionecrosis of the jaws 
(ORN), a condition of impaired wound healing characterised by non-vital bone in radiation 
fields not related to tumour recurrence[1]. Many risk factors for ORN exist including 
radiation dose, field and fractionation, tumour location, smoking and alcohol use, general 
health and nutrition status, oral health and oral hygiene. There also exist triggers that 
increase the likelihood of ORN developing, such as dental extractions, dental implants, 
surgery or poor fitting prostheses [2] as well as any residual foci of infection[76]. 
 
To minimise the risk of ORN and other radiation-related negative effects on the oral cavity, 
it is recommended that all patients are seen by a dental clinician prior to the 
commencement of treatment. At this visit, the oral status is assessed and appropriate 
dental treatments are completed. The dental needs of patients diagnosed with HNC are 
often quite high, and patients frequently present with periodontal disease and caries [13]. 
 
An important factor when understanding treatment effects of neoplastic disease is the 
patient’s quality of life. A cancer diagnosis is often traumatic, and the treatment received 
has significant morbidity. In the case of head and neck cancer treated with RT, there can 
be significant effects on aesthetics, speech, eating and pain, as well as general effects on 
emotional state, social state and a general functional level [7]. There are numerous quality 
of life instruments available for the clinician or researcher to use, with a recent review 
finding 57 separate head and neck specific instruments published [87]. Quality of life 
instruments attempt to measure the human experience in order to produce a meaningful, 
thorough and comparable quantity that can be used to ascertain treatment effectiveness 
beyond the purely biological. This is obviously not an easy task.  
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It is logical on face value and has been reflected in the literature that fewer teeth are 
associated with reduced quality of life [10]. There are no studies published to date on the 
impact of RT related dental extractions on quality of life. As teeth are often extracted in the 
pre-RT period, it is hypothesised that dental extractions in this population result in a 
reduced oral health related quality of life. The competing theory is that pre-RT dental 
extractions provide a protective effect against outcomes that stand to impair quality of life, 
such as ORN, in such a significant way as to overpower the quality of life effect of tooth 
loss and provide a net benefit. In this study we aim to understand the effect that dental 
extractions had on quality of life for patients receiving RT for oropharyngeal cancer (OPC).  
 
Materials and Methods 
Participant selection 
Patients over the age of 18 with OPC treated with curative intent definitive and/ or 
postoperative RT at two tertiary hospitals in an Australian state capital from 2005-2011 
were invited to participate in the study. Patients underwent treatment planning through a 
multidisciplinary head and neck clinic and all received dental assessment, primary dental 
treatment and oral hygiene instruction before being discharged back to community dental 
clinics The dates chosen allowed sufficient post-treatment time to capture late 
complications, specifically ORN with a minimum time of 3 years.  Participants were 
required to be consenting and free to withdraw at any stage as per ethics approval. 190 
participants completed the study, and 47 declined to participate. Data was collected 
between July and December 2014. 
 
Data collection 
Consenting participants had their demographic and treatment data retrieved from hospital 
databases. Age, gender and smoking status were recorded. Diagnostic data included 
tumour location, tissue diagnosis, TNM staging and p16 status. Treatment data included 
radiation dose and site as well as the use and synchronicity of chemotherapy.  
Participants were given questionnaires requesting further information regarding their 
dental health and treatment in the preceding months before, during and following RT. 
Specifically, the location, timing and number of dental extractions were recorded. 
Subjective dental hygiene was recorded for pre- and post-treatment and participants were 
asked to disclose dental habits, denture use and service utilisation. The questionnaire 
gathered information regarding exposed bone after radiation treatment including duration, 
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quadrant location and treatment with either surgical intervention and/or hyperbaric oxygen. 
Location site was confirmed with medical records and radiographs. 
Participants were given two self-reported quality of life instruments, the Oral Health Impact 
Profile 14 (OHIP-14)[88], and the Functional Assessment of Cancer Therapy – Head and 
Neck (FACT Head and Neck)[89] which they completed and returned. As this is a 
retrospective study, there was no opportunity to collect a baseline quality of life 
assessment. 
 
All data was de-identified, tabulated and stored in a secure database.  
The quality of life instruments were administered according to their guidelines.  
OHIP-14 scores were individually calculated based on additive measures.  
FACT Head and Neck scores were individually calculated according to the weighted 
method. Subset scores were recorded according to the Functional Assessment of Chronic 
Illness Therapy (FACIT) guidelines and recorded as physical well-being, social well-being, 
emotional well-being, functional well-being and head and neck specific. Derived scores 
were also calculated according to the guidelines and recorded as FACT-G, FACT-HN 
Total and Fact-HN Trial Outcome Index. FACT-G scores represent a general endpoint 
utilising the subsets of Physical, Social, Emotion and Functional Well Being are 
comparable with other FACIT family scores. FACT- Trial Outcome Index represents a 
physical and functional endpoint, which is calculated from Physical and Functional Well 
Being, and the Head and Neck specific score. The FACT total score encompasses all the 
subsets. 
Data underwent statistical analysis provided by an independent external statistician using 
Stata statistical software v12.0 (Statacorp, College Station, TX, USA).   
 
Results 
190 participants met the criteria and were included in the study, of which 132 (69.5%) were 
from hospital 1, and 58 (30.5%) were from hospital 2.  157 (82.6) were males and 33 
(17.3%) were females. The mean age was 64.9 (34.1-89.0, SD 8.3) with mean female age 
61.2 and mean male age 65.7.  
 
Approximately half of the cases were tonsillar primary tumours (53.7%) followed by base 
of tongue (35.8%). Of known p16 status cases the great majority were positive (87.2%). 
Smoking status was divided into current smokers, ex-smokers and lifelong non-smokers, 
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and respectively represented 16.9%, 54.9% and 28.2%, indicating over three-quarters 
were current or ex-smokers. The majority of histopathological diagnoses were SCC 
(95.3%) (Table 1). 
 
Table 3.1 Participant Demographics  
Tumour Site Cases T Stage Cases Prog 
Stage 
Cases 
Tonsil 102 TX 2 Stage I 5 
Base of 
Tongue 
68 T0 3 Stage II 8 
Soft Palate 3 T1 44 Stage III 31 
Oropharynx 
Other or 
Unspecified 
17 T2 66 Stage 
IVA 
134 
P16 status Cases T3 43 Stage 
IVB 
7 
Positive 102 T4a 27 Not 
recorded 
5 
Negative 15 T4b 1   
Unknown 73 T Not 
recorded 
4   
Smoking 
status 
Count N Stage    
Current 
smoker 
24 N0 22   
Ex-smoker 78 N1 32   
Non-smoker 40 N2a 19   
Unknown 48 N2b 74   
Morphology Count N2c 24   
Squamous 
cell 
carcinoma 
181 N3 6   
Other 9 N Not 
recorded 
4   
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Treatment Modality 
All participants underwent RT as required by the study protocol. 167 (87.9%) underwent 
concurrent chemotherapy and RT. 21 (11.1%) underwent RT alone, and 2 (1.1%) 
underwent sequential chemotherapy and RT. The mean RT dose administered was 68 
Gray (30-77, SD 5.9). 
 
Pre-Radiotherapy Dental Extractions 
4 participants (2.1%) were edentulous prior to treatment. 129 (67.9%) of participants 
underwent dental extractions as part of their pre-RT treatment. 13 of this group underwent 
full clearances. Of the 129 cases who had pre-RT extractions, 20 (15.5%) went on to have 
post-RT extractions, leaving 109 having only pre-RT extractions. The mean number of 
teeth extracted for all cases was 5.1 (Range 0-24, SD 5.4). Teeth were extracted prior to 
RT at a total of 364 quadrant-extractions. More extractions were performed in the 
mandible at a ratio of 1:1.7. Quadrants 1 to 4 had 77, 72, 102 and 113 quadrant-
extractions respectively. 
 
Extractions during radiotherapy 
No participants had dental extractions during RT treatment. 
 
Post-Radiotherapy Dental Extractions 
30 participants underwent post-radiotherapy extractions, with 10 cases having them alone. 
The mean number of teeth extracted after RT for all cases was 0.85 (Range 0-20, SD 3.0). 
Teeth extracted post RT were balanced across the mouth, with extractions from quadrant 
1 to quadrant 4 as 16, 15, 15 and 16 respectively (Table 2). 
 
 Table 3.2 Dental extractions 
Extractions Count 
Pre-RT extractions 129 
Pre-RT full clearance 13 
Pre-RT extractions only 109 
Edentulous prior to 
treatment 
4 
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Post RT extractions 30 
Post RT extractions only 10 
Pre- and Post-RT 20 
Pre- and/or Post-RT 139 
No extractions (Dentate) 47 
 
Osteoradionecrosis 
29 participants (15.3%) had developed ORN at the time of the study. ORN was 5.8 times 
more common in the mandible than the maxilla.  
 
25 of the 29 cases of ORN (86.2%) occurred in participants who underwent pre-RT 
extractions, and 22 of the 29 cases of ORN (75.9%) were in sites of pre-RT extraction. Of 
the 25, 2 cases of ORN developed in participants who had full clearances, and 5 
developed in participants who had both pre- and post-RT extractions. 
 
4 cases of ORN (13.8%) developed in the site of post-RT extraction, and 3 (10.3%) were 
in the same quadrant that had undergone both pre- and post-RT extractions. 2 dentate 
participants developed ORN without undergoing pre- or post-RT extractions. No 
participants who were edentulous at the beginning of treatment developed ORN. 
 
Oral Hygiene Status 
Oral hygiene status was self reported, with an overall status, brushing times per day and 
dental visits per year recorded. Participants gave scores for their hygiene both prior to 
treatment and at the time of questionnaire, reported as poor, fair, good or excellent. Post-
treatment the results polarised and the excellent and poor groups made net gains (Table 
3). 
 
Table 3.3 Oral Hygiene Status 
Oral Hygiene Poor Fair Good Excellent 
Pre-RT 2.6% 19.6% 57.7% 20.1% 
Post-RT 5.8% 11.6% 42.9% 39.7% 
Net change +3.2% -7.9% -14.8% +19.6% 
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Quality of Life Measures 
The range of values representing quality of life was broad, with the OHIP-14 scores 
ranging from the lowest possible score to 3 points below the highest possible score. A 
similar range was found for the FACT-Head and Neck subsets, with the results occupying 
a large proportion of the available options.  
 
It must be noted that the values for the OHIP-14 and the FACT-H&N measures have 
different meanings of their sign, ie a higher score for the OHIP-14 represents a poorer 
quality of life, whereas a higher score for the FACT-Head and Neck represents a richer 
quality of life. To derive the OHIP-14 mean as a percentage of the theoretical maximum, 
the inverse was used as to be more comparable (Table 4). 
 
Table 3.4 Quality of life outcomes 
Instrument Mean Min 
(Actual) 
Max 
(Actual) 
St 
Dev 
OHIP 14 16.1 0 53 12.7 
PWB 23.5 3 28 4.7 
SWB 21.6 0 28 6.6 
EWB 20.0 5 24 4.3 
FWB 22.0 4 28 5.7 
HNCS 27.1 8 40 7.6 
FACT TOI 72.6 19 96 15.7 
FACT G 87.1 36 108 17.1 
FACT H&N 114.2 44 147 22.9 
 
OHIP-14  
From the OHIP-14 data, is can be seen that female gender was associated with a 
significantly worse quality of life (6.8 points). Other outcomes that negatively affected the 
quality of life according to the OHIP-14 score at the 5% level were p16 status and smoking 
status. p16 negative cases had poorer quality of life, as did current and ex-smokers, with 
current smokers faring worse. 
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Pre-RT dental extractions by number revealed that >8 were associated with a significantly 
worse quality of life than those who had no extractions. While 1-7 pre-RT extractions and 
post-RT extractions were associated with a reduced quality of life, this was not found to be 
significant at levels applied. When pre-RT dental extractions were taken as a binary yes or 
no, the effect on the quality of life was negative but not statistically significant. 
 
Other measures associated with a significantly reduced quality of life included pre-RT full 
clearance (14.05, p=0.046), and development of ORN (4.74, p=0.036). Current excellent 
dental hygiene was associated with a slightly improved quality of life (-1.92 points, 
p=0.004). 
 
There was not a great range of RT doses received to determine a significant effect on 
quality of life. When the doses are separated into the groups ‘less than 70 Gray’ and 
‘greater than or equal to 70 Gray’ there is a negative but not significant effect on quality of 
life (3.38, p=0.54). Treatment received i.e. synchronised chemoradiotherapy and other 
intervention groups did not produce significant results, but again there was a great degree 
of homogeneity in the data (Table 5). 
 
Table 3.5 Linear regression for OHIP-14 
OHIP-14 
Variable Coefficient P value 95% Confidence Interval 
Age -0.15 0.119 -0.33 0.04 
Gender (M) -6.84 0.005* -11.53 -2.14 
Morphology -3.33 0.44 -11.87 5.22 
p16 (+ve)  -8.21 0.025* -15.38 -1.03 
Smoking Ex 
vs C 
-6.14 0.039* -11.96 -0.31 
Smoking N vs 
C 
-6.24 0.058* -12.69 0.20 
Pre RT exo 
1-7 vs 0 
3.82 0.090 -0.59 8.23 
Pre RT exo 
>8 vs 0 
4.82 0.033* 0.40 9.23 
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Post-RT exo 3.56 0.16 -1.40 8.52 
 
FACT Head and Neck Subset Scores 
The FACT- Head and Neck subset scores were analysed to further understand if 
associations could be made between particular domains of quality of life and interventions 
received. Here it can be seen that there is a significant association across all domains 
between reduced quality of life and smoking status as either current and or ex compared 
with lifelong nonsmokers. p16 negative cases are associated with reduced quality of life in 
the Social and HNCS domains. Female gender was significantly associated with reduced 
quality of life in the Emotional Well Being domain (Table 6, Table 7). 
 
Table 3.6 Linear regression for FACT Head and Neck 
Physical Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age 0.031 0.38 -0.038 0.099 
Gender (M) 0.78 0.38 -0.98 2.55 
Morphology 1.31 0.41 -1.84 4.47 
p16 (+ve)  .66 0.64 -2.15 3.47 
Smoking Ex 
vs C 
2.27 0.037* 0.14 4.40 
Smoking N vs 
C 
2.78 0.021* 0.42 5.13 
Pre RT exo 
1-7 vs 0 
-0.52 0.53 -2.17 1.12 
Pre RT exo 
>8 vs 0 
-0.07 0.93 -1.72 1.58 
Post-RT exo -0.27 0.77 -2.11 1.57 
Social Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age  -0.01 0.80 -0.11 0.09 
Gender (M) 0.65 0.51 -1.87 3.16 
Morphology 1.50 0.66 -2.98 5.98 
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p16 (+ve)   3.80 0.047* 0.06 7.55 
Smoking Ex 
vs C 
 2.87 0.06 -0.12 5.86 
Smoking N vs 
C 
5.23 0.002* 1.93 8.54 
Pre RT exo 
1-7 vs 0 
 -1.66 0.16 -4.00 0.67 
Pre RT exo 
>8 vs 0 
 -0.71 0.55 -3.05 1.62 
Post RT exo -0.26 0.84 -2.87 2.35 
Emotional Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age  0.04 0.17 -0.19 0.10 
Gender (M) 2.06 0.01* 0.47 3.66 
Morphology 1.33 0.36 -1.55 4.22 
p16 (+ve)  1.07 0.40 -1.44 3.58 
Smoking Ex 
vs C 
 0.97 0.33 -1.01 2.95 
Smoking N vs 
C 
2.53 0.02* 0.34 4.73 
Pre RT exo 
1-7 vs 0 
 -0.75 0.92 -1.59 1.43 
Pre RT exo 
>8 vs 0 
0.21 0.79 -1.31 1.71 
Post RT exo 0.14 0.87 1.54 1.83 
Functional Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age  0.03 0.54 -0.06 0.11 
Gender (M) 0.52 0.63 -1.63 2.70 
Morphology  1.57 0.42 -2.27 5.41 
p16 (+ve)  3.15 0.064 -0.19 6.48 
Smoking Ex  3.75 0.005* 1.13 6.36 
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vs C 
Smoking N vs 
C 
5.13 0.001* 2.24 8.03 
Pre RT exo 
1-7 vs 0 
-1.09 0.29 -3.10 0.92 
Pre RT exo 
>8 vs 0 
-0.22 0.83 -2.22 1.79 
Post RT exo -1.16 0.31 -3.40 1.07 
HNCS 
Variable Coefficient P value 95% Confidence Interval 
Age  0.03 0.65 -0.09 0.14 
Gender (M) 0.76 0.60 -2.11 3.63 
Morphology  1.43 0.58 -3.70 6.55 
p16 (+ve)  4.55 0.035* 0.33 8.77 
Smoking Ex 
vs C 
 4.17 0.017* 0.75 7.60 
Smoking N vs 
C 
3.66 0.058 -0.13 7.44 
Pre RT exo 
1-7 vs 0 
 -2.26 0.096 -4.93 0.40 
Pre RT exo 
>8 vs 0 
-1.150 0.28 -4.13 1.20 
Post RT exo -1.68 0.27 -4.66 1.30 
 
 
Table 3.7 Fact Head and Neck Derived Scores 
FACT TOI  
Variable Coefficient P value 95% Confidence Interval 
Age  0.08 0.48 -0.15 0.31 
Gender (M) 2.07 0.49 -3.85 7.98 
Morphology  4.31 0.42 -6.23 14.86 
p16 (+ve)   8.36 0.069 0.66 17.38 
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Smoking Ex 
vs C 
10.19 0.005* 3.11 17.26 
Smoking N vs 
C 
11.57 0.004* 3.74 19.39 
Pre RT exo 
1-7 vs 0 
 -3.87 0.17 -9.37 1.62 
Pre RT exo 
>8 vs 0 
-1.75 0.53 -7.24 3.75 
Post RT exo -3.12 0.32 -9.25 3.02 
FACT G 
Variable Coefficient P value 95% Confidence Interval 
Age  0.09 0.49 -0.16 0.33 
Gender (M) 4.01 0.22 -2.43 10.46 
Morphology 5.72 0.33 -5.79 17.23 
p16 (+ve)  8.68 0.09* -1.40 18.74 
Smoking Ex 
vs C 
9.86 0.014* 2.06 17.66 
Smoking N vs 
C 
15.68 <0.0001* 7.05 24.31 
Pre RT exo 
1-7 vs 0 
-3.35 0.27 -9.36 2.67 
Pre RT exo 
>8 vs 0 
-0.80 0.80 -6.81 5.22 
Post RT exo -1.55 0.65 -8.27 5.17 
FACT TOTAL 
Variable Coefficient P value 95% Confidence Interval 
Age 0.11 0.51 -0.22 0.45 
Gender (M) 4.78 0.28 -3.87 13.42 
Morphology 7.15 0.36 -8.29 22.59 
p16 (+ve)  13.23 0.051 -0.09 26.54 
Smoking Ex 
vs C 
14.03 0.009* 3.62 24.44 
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Smoking N vs 
C 
19.33 0.001* 7.82 30.85 
Pre RT exo 
1-7 vs 0 
 -5.61 0.17 -13.67 2.44 
Pre RT exo 
>8 vs 0 
-2.26 0.58 -10.31 5.80 
Post RT exo -3.23 0.48 -12.23 5.77 
 
 
Discussion 
Comparison of Quality of Life Instruments 
Murphy et al reports that Quality of Life instruments can be categorised as either site-
specific (in this case, Head and Neck), symptom-specific or treatment-specific[85]. The 
selected instruments have been taken from different groups, namely the FACT- Head and 
Neck is a site-specific instrument, and the OHIP-14 is a symptom-specific instrument[87]. 
It was hypothesised that using instruments from differing paradigms would produce 
meaningful results. Additionally, data gained can introduce a comparison between the two 
instruments, as our literature review did not reveal any study comparing data from the 
OHIP-14 and the FACT- Head and Neck instruments. There was however, one study 
found which compared OHIP-14 to another member of the FACIT family, namely the 
FACT- Bone Marrow Transplant [90]. 
 
The studies have differing strengths and weaknesses. The OHIP-14 is derived from data 
collected from Australians and focuses on oral health symptoms [88]. This is important in 
order to capture any effect from oral hygiene as well as oral health interventions, such as 
dental extractions, as well as resulting in a high level of applicability as the current study 
population are Australian as well. The OHIP-14 is also short, and easy to use. However 
the OHIP-14 relates questions back to teeth, mouth or dentures, whereas the FACT-Head 
and Neck is more general, which may cause some answers to be different between the 
two. An example of this is the OHIP-14 question “Have you had painful aching in your 
mouth” and the FACT-Head and Neck statement “I have pain”. The FACT- Head and Neck 
instrument is utilised for breadth in that it captures general health data, and specificity in 
that the Head and Neck Specific questions have been determined especially for patients 
with head and neck cancer[89]. 
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In this study, the mean of QoL outcomes is similar. The mean score expressed as a 
percentage of the theoretical maximum quality of life is 71.1% for OHIP-14 and 77% for 
FACT- Head and Neck. The OHIP-14 values ranged from the minimum theoretical (ie best 
possible quality of life) score of 0, to a maximum of 53 from the theoretical 56 (worst 
possible OHIP-14 score). Increased values for the two instruments have opposite 
meaning, and it can be seen that the FACT-Head and Neck ranges from a score of 147 of 
theoretical 148 (best possible score) and to a score of 44 from 0 (worst possible score). So 
while the means are comparable, it can be seen that the OHIP-14 reports a wider range, 
and the FACT-Head and Neck has a lesser range of negative quality of life scores. 
 
Demographics 
The participants were derived from two major and similar hospitals of within the same city, 
69.5% from one and 30.5% from the other. The mean age was 64.9 (SD 8.3) and range 
34.1 to 89, which is higher than that of diagnosis in HPV-associated (53 years) and non-
HPV associated (57 years)[91], but when follow up time of 3 to 9 years is included then 
this number approaches that in the literature. 
  
Extractions 
A large number of participants (67.9%) underwent extractions (mean 5.1 teeth) as part of 
their pre-RT work-up. This is in keeping with the literature showing head and neck cancer 
patients present with high dental needs and unmanaged risk factors, poor oral health 
literacy and low engagement with the dental profession, often persisting post-treatment 
[13, 25, 92]. 15.5% (20) of those having pre-RT dental extractions went on to have post-
RT dental extractions, with only 10 participants having post-RT extractions alone.  
 
Oral Hygiene 
Poor pre-RT dental hygiene habits have been published in the literature to persist following 
treatment [92], despite high adherence to oral hygiene methods leading to reduced 
complications [6, 93]. This must be seen as a joint responsibility of the patient and the 
head and neck oncology team, including the dental practitioner. In this study, we found 
that oral hygiene polarised following treatment, whereby the excellent and poor groups 
increased in number, and in fact the excellent group doubled from 20% to 39.7%. This was 
a subjective record, however it shows that despite morbid treatment there is chance of 
improving oral hygiene. All the participants in this study underwent dental consultation and 
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oral hygiene information prior to RT, and it is hypothesised that such oral health education 
and intervention can have a positive impact on hygiene practises. 
 
Quality of Life Outcomes 
This is the first study to the author’s knowledge that investigates the effect of pre-
radiotherapy dental extractions and quality of life. Some comparable data does exist for 
aspects of this study in the form of OHIP-14 and FACT H&N results but due to the large 
number of different instruments used by various institutions, opportunity for direct 
comparison is reduced. 
 
The mean additive OHIP-14 score was 16.1, which is comparable to the score of 18.9 from 
a study of oral and oropharyngeal cancer survivors at least 6 months post-treatment, and 
contrasted to the mean of 5.9 from their control group[94]. Factors significantly reducing 
the quality of life per the OHIP-14 score were found to be female gender, p16 negative 
status, current vs never smoking status, current vs ex-smoking status, pre-RT dental 
extractions >8 and pre-RT full clearance. Development of ORN was associated with a 
worse quality of life. Excellent dental hygiene was found to improve quality of life. 
 
In regards to the FACT- Head and Neck scores, similar results were found. Smoking 
status resulted in worse quality of life outcomes in the domains of physical, social, 
emotional and functional well-being. P16 negative status worsened social well-being, head 
and neck specific scores and FACT-G (general) scores. Female gender worsened quality 
of life in the emotional well-being domain.  
 
Importantly, dental extractions both pre- and post-RT did not have a positive effect on 
quality of life post-treatment. While extractions did not have a significant relationship 
(beyond >8 extractions and OHIP-14 score), both groups were associated with negative 
effects on quality of life. 
 
Smoking status has been found to be a predictor of not only post-treatment oral health 
related quality of life, but general health related quality of life in head and neck cancer 
survivors[8], and the current study confirms this relationship extends to a tiered system 
where current smokers, ex-smokers and non-smokers have improving quality of life. 
Additionally, our study confirms the previous findings that p16 positive cases have better 
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quality of life over their counterparts [95], often attributed to improved survival, younger 
age and lack of smoking, although other studies have found no difference [96]. 
 
It is interesting but not surprising that excellent dental hygiene was associated with an 
improved quality of life score. Improved oral hygiene should lead to improved oral function, 
and then translate into measurable quality of life differences. 
 
Clinical Implications 
The clinical implications are broad. Firstly, the dental needs of head and neck cancer 
patients are high, and clinicians should make the management of this a priority, as oral 
hygiene can improve, and is associated with the development of post-treatment 
complications. Secondly, dental extractions prior to RT do not improve post-treatment 
quality of life, and may worsen it. Such extractions therefore require great consideration. 
Thirdly, there are modifiable risk factors that can improve quality of life, namely smoking 
status, as well as non-modifiable risk factors such as female gender and HPV status that 
clinicians should identify as requiring greater support from a quality of life perspective.  
 
Further Research 
The domains covered by quality of life instruments in the head and neck population have a 
large amount of consistency. However, with more than 57 instruments to choose from, 
there is a great need that the advocates for various quality of life instruments in produce or 
choose a standard instrument, available freely and in multiple languages, so that the 
international community may benefit from improved communication of collected data and 
enable higher powered statistical comparison. A higher powered and prospective study 
investigating dental extractions and quality of life would add great weight to this 
discussion. 
 
Limitations 
It is prudent to address the limitations of a study before discussing the merits of the results 
so as to ensure the outcomes are viewed in the correct light, and, more importantly, that 
future studies may be planned accordingly to account for such limitations and produce 
higher quality data. 
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In this study, there are number of limitations. There is no true control, nor is there a pre-
treatment quality of life baseline, and there is evidence to suggest that longer term quality 
of life relates to baseline[84, 85]. Due to the nature of the study design, there are 
opportunities for bias to occur with participants selecting into and out of the study due to 
personal reasons, for example, developing ORN and desiring to express their concerns. 
Additionally there is survivorship bias, as all participants have been able to complete the 
requirements of the study, which selects for p16 positive malignancies and the inherent 
prognostic factors [9, 86]. 
 
 
Conclusion 
Pre-radiotherapy dental extractions may impact health-related quality of life. 
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Chapter 4: 
Thesis Conclusion 
 
Dental Management of the Irradiated Patient 
Dental management of the irradiated patient is firstly reduction of the disease burden and 
management of dental and periodontal disease prior to radiotherapy, followed by life-long 
intensive oral hygiene. The role of oral hygiene information (OHI) and education should not 
be diminished, as can be found in this study where all participants received 
comprehensive OHI and the group reporting excellent hygiene post-radiotherapy nearly 
doubled. 
 
As radiotherapy delivery technology changes to deliver a lesser dose to major salivary 
glands and alveolar bone, so dental dogma must also be challenged. Teeth can be 
maintained following radiotherapy, and ORN can be dramatically minimised by both 
elimination of foci of infection and continuous intensive oral hygiene measures. 
  
Dental Extractions and Osteoradionecrosis 
This study has shown that pre-radiotherapy dental extractions in increasing number are 
associated with a statistically significant increase in ORN, both as a yes/no and per 
extraction. Post-radiotherapy extractions were associated with an increased risk of ORN, 
however this was not statistically significant and there were a relatively small number of 
extractions. While it could be argued that denying pre-radiotherapy dental extractions is 
merely kicking the can down the road, it was also found that the majority of those who had 
post-radiotherapy dental extractions had pre-radiotherapy extractions as well. It is 
therefore important to divide these extractions into two groups; those that are prompted by 
significant disease burden, and those that are performed in the name of prophylaxis. 
Although this study is not powered enough to determine the extraction indication, it has 
been shown that any extraction confers a risk; in no situations were increased dental 
extractions associated with a reduction in the risk of ORN. Prophylactic dental extraction 
prior to radiotherapy should therefore, be questioned, as it may in fact be triggering the 
disease it is designed to reduce.  
 
In regards to demographics, this study did not show an increased risk for age or gender in 
regards to ORN, however the treatment group was quite homogenous in this regard. It was 
shown that smokers who continue their habit following radiotherapy are at an increased 
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risk of developing ORN. No tumour subgroup was associated with a higher risk, but again 
the population was fairly homogenous and the anatomical location was restricted to the 
oropharynx. It was shown, however, that p16-ve status was associated with a higher risk 
of ORN; this is possibly a result of the different characteristics of the two populations such 
as age and risk factors, as well as treatment protocols that this study was not powered 
enough to identify.  
 
Health-related Quality of Life 
This study is the first to investigate quality of life of head and neck cancer patients in 
regards to their dental extractions. In addition to increasing the risk of ORN, dental 
extractions have not been shown to be associated with an improved health-related quality 
of life. Greater than 8 pre-radiotherapy dental extractions were shown to be associated 
with a statistically significant reduced quality of life, as were pre-radiotherapy full 
clearances and the development of ORN. No timing or number of dental extractions was 
shown to be associated with a statistically significant improved quality of life compared to 
no dental extractions.  
 
The OHIP-14 and FACT H&N did not find an association between age and quality of life, 
however the population studied had a small age range. Female gender was associated 
with a lower quality of life on both dimensions, and specifically related to emotional 
wellbeing. Tumour location and treatment was not associated with a statistically significant 
difference in quality of life, however this was largely restricted by inclusion criteria. P16-
negative cases were associated with a worsened quality of life; this is probably due to the 
inherent differences in these populations that were not able to be captured by this study. 
Smoking status was associated with reduced quality of life in a graded fashion with current 
smokers recording worse scores than ex-smokers and non-smokers respectively, and this 
was shown to be in a number of domains, such as physical, social, emotional and 
functional well-being. Development of osteoradionecrosis was predictably associated with 
a worse quality of life. 
 
Excellent dental hygiene was shown to be associated with a statistically significant higher 
quality of life.  
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Further Research 
This study has shown that any extraction confers a risk of ORN when compared to no 
extractions. On this basis prophylactic extractions should not be performed, and the teeth 
should be maintained as best as possible.  However, the dental needs of head and neck 
cancer patients are high and frequently patients present needing dental extractions 
regardless of any planned radiotherapy. In these cases the only factors that can be 
manipulated are the extraction technique, use of adjuvant therapies such as HBO and the 
extraction timing. Pre-radiotherapy extractions have a limited lead time owing to the cancer 
diagnosis and necessary for prompt delivery of radiotherapy, however there are currently 
no randomised controlled trials regarding best timing of necessary dental extractions and 
osteoradionecrosis.  
 
Further research in terms of improving quality of life in cancer survivors should be 
undertaken to confirm the finding that remaining dentate results in improved quality of life 
and whether or not prosthodontic rehabilitation can restore the deficit caused by the 
edentulous state.  
 
Final Comments 
This thesis has shown two important points, firstly that pre-radiotherapy dental extractions 
do not appear to reduce the risk of developing ORN, and secondly, that pre-radiotherapy 
dental extractions do not appears to improve post-treatment quality of life. It is a 
reasonable conclusion that the practice of removing teeth as prophylaxis prior to 
radiotherapy be highly questioned.  
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